OTC · Financial Statements

Anebulo Pharmaceuticals, Inc. (ANEB) Financial Statements

$0.34 OTC: ANEB Market Cap $13.72M

Anebulo Pharmaceuticals, Inc. most recently reported annual revenue of $0, net profit of $-8.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-4.0M$-7.0M$-12.0M$-8.0M$-9.0M
Net Profit$-30.0M$-7.0M$-12.0M$-8.0M$-8.0M
EPS$-1.30$-0.29$-0.47$-0.32$-0.25
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$22.0M$16.0M$12.0M$4.0M$12.0M
Total Liabilities$0$1.0M$1.0M$0$0
Cash$20.0M$15.0M$11.0M$3.0M$12.0M
Borrowings$0$0$0$0$0

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-5.0M$-5.0M$-10.0M$-8.0M$-6.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$-1.0M$0$0$0$0
Net Cash Flow$17.0M$-5.0M$-3.0M$-8.0M$9.0M
Free Cash Flow$-5.0M$-5.0M$-10.0M$-8.0M$-6.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.04
EV / EBITDA-0.63
FCF Yield-42.57%
Quick Ratio16.71
Interest Coverage-30.60
Return 1Y-79.76%
Return 3Y-86.61%
Return 5Y-95.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
ANEB Overview ANEB Dividend Run Stock Screener